Table. 2.

Baseline characteristics and clinical outcomes according to amount of enteral nutrition before liver transplantation

Variable Pre-LT enteral nutrition <25% Pre-LT enteral nutrition ≥25% P-value
Patient 6 (19.4) 25 (80.6)
Age (yr) 57.5±6.66 54.6±7.6 0.391
Sex 0.141
Male 6 (100.0) 15 (60.0)
Female 0 10 (40.0)
BMI (kg/m2) 22.63±3.53 24.13±3.13 0.174
PMI (cm2/m2) 11.08±4.64 12.50±3.64 0.422
LT type 0.002
DDLT 6 (100.0) 7 (28.0)
LDLT 0 18 (72.0)
HCC 0.358
Yes 3 (50.0) 7 (28.0)
No 3 (50.0) 18 (72.0)
Post-LT enteral nutrition grade 1.000
Poor 1 (16.7) 6 (24.0)
Moderate 4 (66.7) 13 (52.0)
Good 1 (16.7) 6 (24.0)
Readmission 0.172
Yes 5 (83.3) 11 (44.0)
No 1 (16.7) 14 (56.0)
Readmission due to infection 0.016
Yes 3 (50.0) 1 (4.0)
No 3 (50.0) 24 (96.0)
Blood chemistry
Platelet (×103/µL) 55,000±39,000 66,520±33,916.7 0.339
PT-INR 2.35±0.98 2.69±1.86 1.000
Total bilirubin (mg/dL) 15.19±11.9 14.31±13.97 0.478
Cr (mg/dL) 0.97±0.34 0.89±0.49 0.291
Albumin (g/dL) 3.28±0.37 3.49±0.62 0.291
Ammonia (µMol/L) 53±21.05 68.04±39.84 0.419
MELD baseline 23.5±8.76 20.92±12.65 0.391
Post-LT care
ICU stay (day) 9.17±3.43 6.32±4.27 0.053
Mechanical ventilation (day) 2.83±1.17 2.08±1.5 0.117
Post-LT admission (day) 27.5±6.86 28.2±16.23 0.419
Post-LT enteral nutrition start (day) 5±2.45 3.84±2.36 0.158

Values are presented as number (%) or mean¡¾standard deviation.

LT, liver transplantation; BMI, body mass index; PMI, psoas-muscle index; LT, liver transplantation; DDLT, deceased donor liver transplantation; LDLT, living donor liver transplantation; HCC, hepatocellular carcinoma; PT, prothrombin time; INR, international normalized ratio; Cr, creatinine; MELD, Model for End-Stage Liver Disease; ICU, intensive care unit.

Korean J Transplant 2020;34:38~46 https://doi.org/10.4285/kjt.2020.34.1.38
© Korean Journal of Transplantation